Cipla receives regulatory approval for launch of Ciplenza (Favipiravir 200 mg) in India to treat mild to moderate COVID-19... Jul 27
Cipla and Brinton Pharmaceutical's cheap Favipiravir to hit the market soon... Jul 24
Pune based Brinton Pharmaceutical gets DGCI nod for Favipiravir... Jul 24
-Advertisements-